This is the first investigation of B. coagulans MTCC 5856 as a single probiotic agent at a dose of 2 × 109 spores (cfu) per day which demonstrated efficacy and security in the patients experiencing MDD symptoms with IBS. The every day food intake of the patients was recorded in the patient diaries provided to them at Visit 1 (Day 0). The same was checked and...
3 monthsAdvertising - Public Relations81707 - Lange Strasse 6128 views
DiegoMoench
3 months
